References
- KnaakJBDaryCCOkinoMSParameters for carbamate pesticide QSAR and PBPK/PD models for human risk assessmentRev Environ Contam Toxicol20081935321220614344
- AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
- HagensWIOomenAGde JongWHCasseeFRSipsAJWhat do we (need to) know about the kinetic properties of nanoparticles in the body?Regul Toxicol Pharmacol200749321722917868963
- NestorovIWhole body pharmacokinetic modelsClin Pharmacokinet2003421088390812885263
- FouchecourtMBeliveauMKrishnanKQuantitative structure-pharmacokinetic relationship modellingSci Total Environ20012741–312513511453289
- LiMAl-JamalKTKostarelosKReinekeJPhysiologically based pharmacokinetic modeling of nanoparticlesACS Nano20104116303631720945925
- LankveldDPOomenAGKrystekPThe kinetics of the tissue distribution of silver nanoparticles of different sizesBiomaterials201031328350836120684985
- AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticlesInt J Pharm20032591–211512712787641
- MacCalmanLTranCLKuempelEDevelopment of a bio-mathematical model in rats to describe clearance, retention and translocation of inhaled nano particles throughout the bodyJ Phys Conf Ser20091511012028
- DaviesBMorrisTPhysiological parameters in laboratory animals and humansPharm Res1993107109310958378254
- DavdaJPJainMBatraSKGwiltPRRobinsonDHA physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructsInt Immunopharmacol20088340141318279794
- EgbariaKFriedmanMAdsorption of fluorescein dyes on albumin microspheresPharm Res1992956296351608894
- SourisJSLeeCHChengSHSurface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticlesBiomaterials201031215564557420417962
- ChoMChoWSChoiMThe impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticlesToxicol Lett2009189317718319397964
- SarbuCOnisorCPosaMKevresanSKuhajdaKModeling and prediction (correction) of partition coefficients of bile acids and their derivatives by multivariate regression methodsTalanta200875365165718585127
- HuynhNTRogerELautramNBenoitJPPassiraniCThe rise and rise of stealth nanocarriers for cancer therapy: passive versus active targetingNanomedicine (Lond)2010591415143321128723
- BermanEMEssential Statistics for Public Managers and Policy Analysts2nd edWashington DCCQ Press2006
- LeeHALeavensTLMasonSEMonteiro-RiviereNARiviereJEComparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic modelNano Lett20099279479919128005
- LinPChenJWChangLWComputational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in miceEnviron Sci Technol200842166264627018767697
- PeryARBrochotCHoetPHNemmarABoisFYDevelopment of a physiologically based kinetic model for 99 m-technetium-labelled carbon nanoparticles inhaled by humansInhal Toxicol200921131099110719814607
- MosqueiraVCLegrandPMorgatJLBiodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and densityPharm Res200118101411141911697466
- PanyamJLabhasetwarVDynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cellsPharm Res200320221222012636159
- ZhangSLiJLykotrafitisGBaoGSureshSSize-dependent endocytosis of nanoparticlesAdv Mater20092141942419606281
- CartieraMSJohnsonKMRajendranVCaplanMJSaltzmanWMThe uptake and intracellular fate of PLGA nanoparticles in epithelial cellsBiomaterials200930142790279819232712
- ChithraniBDChanWCElucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapesNano Lett2007761542155017465586
- SerdaREGuJBurksJKFerrariKFerrariCFerrariMQuantitative mechanics of endothelial phagocytosis of silicon microparticlesCytometry A200975975276019610127